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Abstract: The demand for medical device software continues to grow and there is an associated 
increase in its importance and complexity. This paper discusses medical device software process 
assessment and improvement. It outlines Medi SPICE, a software process assessment and 
improvement model which is being developed to meet the specific safety-critical and regulatory 
requirements of the medical device domain. It also details the development of a subset of the Medi 
SPICE process reference model for inclusion in the next release of the IEC 62304 standard: Medical 
device software - Software life cycle processes. IEC 62304 is a key standard for medical device 
software development and is approved by many national regulatory bodies including the Food and 
Drug Administration in the United States and the European Union. This paper also outlines 3 
lightweight software process assessment methods which have been developed in tandem with Medi 
SPICE. Finally the timeline for the release of the full Medi SPICE model is provided.  
1.  INTRODUCTION 
Today Information Technology (IT) increasingly performs an essential role in the provision of 
healthcare services (Abraham et al., 2011).  This is particularly  reflected in the importance that  IT 
now plays in medical diagnoses and treatment (Hanna et al., 2011).  To facilitate this development 
the level of software functionality in medical devices  and the complexity of that software has 
substantially  increased in the last number of years (Rakitin, 2006). The importance that software 
now plays in medical devices has been acknowledged by the European Union (EU). This is 
demonstrated in the latest amendment to the Medical Device Directive (MDD) 2007/47/EC 
(European Council, 2007), which now recognizes that standalone software can be classified as an 
active medical device in its own right.  Likewise in the United States (US) the Food and Drug 
Administration (FDA) have recently provided guidance in relation to medical device data systems  
(US FDA, 2011a)  and draft guidance in relation to mobile  applications for medical use (US FDA, 
2011b). 
While the importance that medical device software plays is now recognized, it is also realized that it 
can be difficult to both successfully develop and achieve regulatory approval for its placement on 
the market (Mc Caffery et al., 2010a).  This is due to the safety-critical nature of medical device 
software which must be developed to comply with numerous specific regulations and international 
standards. These are dictated by the regulatory requirements of the geographical location where the 
medical device is to be marketed (Burton et al., 2006).  
Although guidance is available from regulatory bodies in terms of what software activities must be 
performed, no specific methods for performing these activities are provided.  As a result, medical 
device software development organizations have been compliance centric in their approach. This 
has resulted in very limited adoption of software process improvement in the medical device domain 
(Denger et al., 2007).  Until relatively recently, this was not such an important issue due to the 
limited proportion of software in medical devices.  This is no longer the case and there is now a 
particular requirement for highly effective and efficient software development processes to be in 
place.  These processes need to be defined in a regulatory compliant manner and then adopted to 
produce the required deliverables in order to achieve approval from the relevant body (Mc Caffery 
et al., 2010a).    
To address the requirement to identify, assess, and assist with the implementation of these 
processes Medi SPICE is currently under development. The objective of Medi SPICE is to provide a 
software process assessment and improvement model that meets the specific requirements of the 
medical device industry (Mc Caffery and Dorling, 2010).  The development of Medi SPICE is being 
undertaken by the Regulated Software Research Group (RSRG) at Dundalk Institute of Technology 
(DkIT) in association with the SPICE User Group, international standards bodies and representatives 
from the medical device software industry. This collaborative process is a key aspect of the 
development of Medi SPICE. 
While a Medi SPICE assessment can be used to evaluate and initiate software process improvement, 
it may also be used for supplier selection. In this context, the results from an assessment may be 
used as criteria for selecting a supplier, when an organization wishes to outsource or offshore part or 
all of its medical device software development (Mc Caffery and Dorling, 2009). This is important, as 
today software has truly become a globally sourced commodity (Casey, 2010). As a result the level of 
globally distributed software medical device development continues to increase  (Sudershana et al., 
2007) (Klein et al., 2010).  Given the mission critical nature of medical device software and the need 
for regulatory compliance, supplier selection is a key activity for medical device organizations and 
Medi SPICE can be utilized to help address this need.  
The rest of this paper is structured as follows: In section 2, we discuss the regulatory requirements 
for medical device software development. In particular we focus on IEC 62304:2006 (IEC 
62304:2006, 2006) and the important role it plays. We also consider the requirements for the next 
release of the IEC 62304 standard. In section 3, we provide an overview of Medi SPICE which 
includes its development, structure and processes. In section 4, we outline the development of the 
IEC 62304 Medi SPICE Process Reference Model (PRM). This is based on the structure of ISO/IEC 
12207:2008 (ISO/IEC 12207:2008, 2008) and is a subset of the Medi SPICE PRM.  It is planned that 
this PRM will be included in the appendix of the next release of the IEC 62304 standard.  In section 5, 
we discuss the lightweight process assessment methods we have developed in tandem with Medi 
SPICE.  We also briefly outline our findings from undertaking a lightweight Medi SPICE-Adept 
assessment in Ireland and Australia.  Finally in sections 6, we provide our conclusions and future 
work including the timeline for the release of the full Medi SPICE process assessment and 
improvement model.   
2. MEDICAL DEVICE SOFTWARE REGULATION 
Regulations, international standards, technical reports and guidance documents play a key role in 
medical device software development.  As stated this is due to the safety-critical nature of medical 
device software and the need for organizations developing such software to minimize the risk of 
failure and the prevention of harm to patients, clinicians and third parties. To address this, 
governments have defined regulatory requirements and established auditing bodies to ensure that 
only safe medical devices are placed on the market (Burton, 2009).   
The FDA is responsible for medical device regulation and approval in the US. To provide assistance in 
achieving regulatory approval, the FDA have published  a number of guidance documents which 
outline essential activities to be performed during software validation (US FDA Center for Devices 
and Radiological Health, 2002), pre-market submission (US FDA Center for Devices and Radiological 
Health, 2005) and when using off-the-shelf software in a medical device (US FDA Center for Devices 
and Radiological Health, 1999). Although the FDA guidance documents provide general information 
on which software activities should be performed, they do not provide specific details on how they 
should be undertaken.   
In the EU the CE mark is required to market a medical device. The requirements for the  
achievement of the CE mark  are outlined in the  Medical Device Directive (MDD) 1993/42/EE 
(European Council, 1993) and its latest amendment MDD 2007/47/EC (European Council, 2007), the 
Active Implantable Medical Device Directive (AIMDD) 90/385/EEC (European Council, 1990) and the 
In-Vitro Diagnostic Directive (IVDD) 98/79/EC (European Council, 1998). The applicable directive(s) 
depend on the type of medical device being developed.    
While these directives must be adhered to, they provide very limited information regarding the 
specific requirements for medical device software development. This is exemplified by the latest 
amendment MDD 2007/47/EC which states: “For devices which incorporate software or which are 
medical software in themselves, the software must be validated according to the state of the art 
taking into account the principles of development lifecycle, risk management, validation and 
verification”.  The term “state of the art” is not defined  and as a result many organizations 
developing medical device software for sale in the EU  rely on the regulatory guidance documents 
provided by the FDA (Mc Caffery et al., 2010a).  
In order to market a medical device in China, approval must be obtained from the State Food and 
Drug Administration (SFDA). In Australia, approval and registration is provided by the Therapeutic 
Goods Administration (TGA) and in Canada, by Health Canada.  Auditing bodies performing similar 
roles exist in other countries including Brazil, Japan, India, South Korea, Singapore, Mexico and New 
Zealand. 
To achieve compliance with national and regional regulatory requirements, conformance with a 
number of international standards and technical reports are recommended by auditing bodies, these 
include: IEC 62304:2006 (IEC 62304:2006, 2006),  ISO 14971:2007 (ISO 14971:2007, 2007), ISO 
13485:2003 (ISO 13485:2003, 2003), EN 60601-4:2000 (BS EN 60601-1-4:2000, 2000),  IEC/TR 80002-
1:2009 (IEC/TR 80002-1:2009, 2009) , IEC 62366:2007 (IEC 62366:2007, 2007), IEC/TR 61508:2005 
(IEC/TR 61508:2005, 2005), and IEC 60812:2006 (IEC 60812:2006, 2006).  A number of these 
standards are harmonized with the European MDD and approved by the FDA. These include ISO 
14971:2007, ISO 13485:2003, and IEC 62304:2006. 
2.1 Risk Management 
To determine the level of regulatory compliance that is required for medical devices, auditing bodies 
have adopted predefined classification schemes based on hazard/risk posed by the medical device. 
The FDA has 3 levels of concern and in the EU the MDD has 4 classes based on perceived potential 
hazard, ranging from low risk to high risk. Medical devices are evaluated against the relevant scheme 
and classified. The manufacturer of the device is then required to establish design controls in line 
with the medical device’s classification level. The higher the classification of the device, the more 
stringent the design controls and constraints that must be complied with (Mc Caffery et al., 2010a).  
ISO 14971:2007 Medical Devices - Application of risk management to medical devices is the de facto 
standard for medical device risk management (Burton, 2009).  The FDA recognizes ISO 14971:2007 
as an approved standard and considers compliance with it acceptable for meeting the risk 
management requirements for medical device premarket submissions. The FDA also provide their 
regulators with training in the standard as part of their  software risk management training (Mc 
Caffery et al., 2010a).   The EU also consider ISO 14971:2007 as a harmonized standard and 
conformance with the standard is acceptable for meeting the risk management requirements of the 
MDD (Harvey, 2003).   In Canada, ISO 14971:2007 is a recognized standard by Health Canada. In both 
Japan and Australia, it has also become the industry standard for managing medical device risk. 
While ISO 14971:2007 is the standard that medical device software organizations must conform to, 
it was developed to address the requirements of developing a medical device as a whole. Until 
relatively recently medical devices were mostly hardware with only a small level of software 
content.  As a result there is a lack of specific information as to how ISO 14971:2007 should be 
applied for medical device software development. To address this a technical information report  
IEC/TR 80002-1:2009 was released to provide specific guidance on how ISO 14971:2007 should be 
applied when developing medical device software (Vogel, 2010).    
2.2  Quality Management System  
A key requirement for medical device development is that a quality management system is in place. 
The FDA define a quality system as “the organizational structure, responsibilities, procedures, 
processes, and resources for implementing quality management” (US FDA, Revised April 1, 2011). By 
ensuring conformance to the requirements of a quality management system, medical device 
organizations have the structure and support in place to facilitate a controlled development 
environment. With the objective of providing greater reliability, safety, and the effectiveness of the 
devices they produce (Mc Caffery et al., 2010a).  Conformance with the requirements of 21 CFR Part 
820 Quality System Regulations (US FDA, Revised April 1, 2011)  is central to achieving FDA approval 
in the US.  ISO 13485:2003 Medical device - Quality management systems- Requirements for 
regulatory purpose is the international standard used for and audited against for medical device 
development. This standard is harmonized with the European MDD and recognized by the FDA. 
2.3 Medical Device Software Life Cycle Processes 
As software components were added to medical devices, manufacturers had to consider how 
software could be developed to ensure that it minimized risk and the possibility of failure.  The 
medical device industry took the decision to recognize ISO/IEC 12207:1995 Information Technology - 
Software life Cycle Processes  (ISO/IEC 12207:1995, 1995) (a general software engineering life cycle 
processes standard) to address this situation.  Subsequently, the Association for the Advancement of 
Medical Instrumentation (AAMI) software committee reviewed ISO/IEC 12207:1995 and identified a 
number of shortcomings due to the fact that it was a generic standard. 
As a result a decision was taken to create a new standard which was domain specific to medical 
device software development. When developing this standard  the AAMI did not discard the work 
done with ISO/IEC 12207:1995 and used it as the foundation for AAMI SW68:2001 (ANSI/AAMI 
SW68:2001, 2001). In 2006, a new standard IEC 62304:2006 Medical device software - Software life 
cycle processes, was released which was based on the AAMI SW68:2001 standard. 
IEC 62304:2006 is approved by the FDA and is harmonized with the European MDD.  It provides 
coverage of the key medical device software development processes. Software developed using the 
IEC 62304:2006 standard is based on  the assumption that  it is developed and maintained in 
accordance with a quality management standard (e.g. ISO 13485:2003), and the risk management 
standard ISO/IEC 14971:2007. Both ISO 13485:2003 and ISO/IEC 14971:2007 are considered to be 
aligned standards with IEC 62304:2006 and their relationship is documented in (IEC 62304:2006, 
2006). 
IEC 62304:2006 is software specific in focus and does not address system level processes which 
include Requirements Elicitation and Validation.   These are addressed by its aligned standards and  
ISO/IEC 15288: 2002 (ISO/IEC 15288:2002, 2002).    ISO/IEC 12207:1995 AMD 1:2002 (ISO/IEC 
12207:1995/Amd.1, 2002) and AMD 2:2004 (ISO/IEC 12207:1995/Amd.2, 2004). These are the 
foundations on which IEC 62304:2006 was developed and their relationship is documented in Annex 
C of the IEC 62304:2006 standard.    
2.4 The Release of ISO/IEC 12207:2008  
ISO/IEC 12207:1995 AMD 1 and AMD 2 was recognized as comprehensive in its approach to general 
software development and a number of standards in addition to IEC 62304:2006 were derived from 
it.  These  include ISO 15504-2:2003 (ISO/IEC 15504-2:2003, 2003), ISO/IEC 15504-5:2006 (ISO/IEC 
15504-5:2006, 2006) and ISO/IEC 90003:2004 (ISO/IEC 90003:2004, 2004).  The importance the 
standard plays is reflected in the fact ISO/IEC 15504-2:2003 and the ISO/IEC 15504-5:2006 PRM are 
derived directly from ISO/IEC 12207:1995 AMD 1 and AMD 2.  
An extensive revision of the ISO/IEC 12207 standard took place. This was undertaken in parallel with 
the revision of ISO/IEC 15288:2002. This resulted in the release in 2008 of ISO/IEC 12207:2008 
Systems and software engineering - Software life cycle processes.  The focus of the new standard is 
no longer just the software engineering life cycle processes; it now addresses the system 
engineering processes as well.  The structure of the standard has been amended to reflect this 
change.   
As a result, standards which are derived from ISO/IEC 12207:1995 AMD 1 and AMD 2 are being 
updated to conform to the new structure of ISO/IEC 12207:2008. These include the next release of 
ISO/IEC 15504-5 and IEC 62304 which are currently under review. Medi SPICE will also conform to 
the new structure of ISO/IEC 12207:2008.  
3 MEDI SPICE 
As outlined in section 1, Medi SPICE is a software process assessment and improvement model 
which is being developed to meet the specific requirements of the medical device industry (Mc 
Caffery et al., 2010b). The results of a Medi SPICE assessment may be used to indicate the state of a 
medical device suppliers software practices in relation to the regulatory requirements of the 
industry, and identify areas for process improvement (Mc Caffery and Dorling, 2010). The results of 
an assessment may also be used as criteria for supplier selection (Mc Caffery and Dorling, 2009). The 
overall objective of Medi SPICE is to provide a conformity assessment scheme to support first, 
second or third party assessment results that may be recognized by the regulatory bodies. 
Medi SPICE is based upon ISO/IEC 15504-5 and provides coverage of the medical device regulations, 
and standards. These include the FDA regulations and guidelines, the European MDD and the 
associated approved and harmonized standards and technical reports  (Mc Caffery et al., 2010a). 
Medi SPICE contains a PRM and a Process Assessment Model (PAM) 
The development of Medi SPICE commenced in 2008 with an extensive literature review and a 
number of preliminary studies.  This phase of the research culminated in the identification of the 
context and strategy for the development of Medi SPICE.  This aspect of the research has been 
published in Medi SPICE: An Overview (Mc Caffery and Dorling, 2009), Medi SPICE Development (Mc 
Caffery and Dorling, 2010) and Software Process Improvement in the Medical Device Industry (Mc 
Caffery et al., 2010a).  In 2010 work commenced on the development of a preliminary PRM and PAM 
(Mc Caffery et al., 2010b).  The preliminary PRM & PAM contained 11 processes: 
 
• Software Requirements Elicitation  
• System Architectural design  
• System Requirements Analysis  
• Software Requirements Analysis  
• Software Construction  
• Software Integration  
• Software Testing 
• Configuration Management 
• Change Request Management  
• Software Verification 
• Software Validation 
 
These processes were based on the structure of ISO/IEC 15504-5:2006 and ISO/IEC 12207:1995 AMD 
1 and AMD 2. They were developed to meet the specific requirements of the relevant medical device 
regulations, standards and guidance documents.  In addition, they also conformed to the 
requirements of ISO/IEC 15504-2:2003 for a PRM and PAM. On completion, these processes were 
released for review by the ISO/IEC 15504 community and representatives from the medical device 
software industry.  These processes have been subsequently updated and amended to bring them in 
line with ISO/IEC 12207:2008 and the latest version of ISO/IEC 15504-5 (currently under ballot). In 
addition the number of processes has been increased.    
3.1 The Medi SPICE Process Reference Model (PRM) 
The Medi SPICE PRM contains the set of medical device software lifecycle processes that are 
fundamental to the development of good quality medical device systems.  The PRM outlines the 
purpose of each process and the outcomes that must be accomplished to achieve that purpose.   
The Medi SPICE PRM contains 2 sets of life cycle processes. These are the Systems Life Cycle 
Processes and the Software Life Cycle Processes. These consist of 42 processes and 15 subprocesses 
which are structured as follows:                                                 
 
The System Life Cycle Processes (contains)  
• 3 Agreement Processes and 7 Subprocesses; 
• 6 Organizational Project - Enabling Processes and 6 Subprocesses; 
• 7 Project Processes; 
• 10 Technical Processes and 2 Subprocesses.   
The Software Life Cycle Processes (contains)  
• 6 Software Implementation Processes; 
• 9 Software Support Processes which includes a medical device specific process Hazard 
Mitigation;  
• 1 Supplementary Process   
3.2 The Medi SPICE Process Assessment Model (PAM) 
The Medi SPICE PAM is related to the Medi SPICE PRM and forms the basis for collecting evidence 
and the rating of process capability. To achieve this it provides a two-dimensional view of process 
capability. In one dimension, it describes a set of process specific practices that allow the 
achievement of the process outcomes defined in the PRM; this is termed the process dimension.  
In the other dimension, the PAM describes capabilities that relate to the process capability levels 
and process attributes, this is termed the capability dimension. Indicators for process capability are 
generic practices that are applicable to any process and associated with process attributes, generic 
work products and generic resources that can be observed when a particular process attribute is 
achieved (ISO/IEC 15504-2:2003, 2003). In line with ISO/IEC 15504 the Medi SPICE process capability 
is defined over 6 levels:  
 
• Level 0 Incomplete; 
• Level 1 Performed; 
• Level 2 Managed; 
• Level 3 Established; 
• Level 4 Predictable; 
• Level 5 Optimizing. 
 
The Medi SPICE PRM and PAM are being released in stages and each stage is extensively reviewed 
prior to release.  
3.3 The Medi SPICE and IEC 62304:2006  
Given the importance of IEC 62304:2006 to medical device software development, conformance to 
this standard plays a key role in the development of Medi SPICE along with its aligned standards. As 
discussed in section 2, IEC 62304:2006 is currently being revised.  As part of this revision, it is being 
aligned with ISO 12207:2008; it therefore requires that IEC 62304 should contain a PRM.  As stated it 
is proposed the IEC 62304 revision will contain a subset of the Medi SPICE PRM (the Medi SPICE 
processes that will be included in the revision of IEC 62304). This will enable the relevant IEC 62304 
processes to be comparable with those of ISO 12207:2008. It will also provide IEC 62304 with a PRM 
that may be used as the foundation for a process assessment model specifically for compliance with 
this standard.   
4 DEVELOPMENT OF THE IEC 62304 MEDI SPICE PRM   
The first step in the development of the IEC 62304 Medi SPICE PRM was the identification of the 
ISO/IEC 12207:2008 processes which were directly relevant to IEC 62304:2006. This was facilitated 
by the fact that IEC 62304:2006 documents its relationship to ISO/IEC 12207:1995 AMD 1 and AMD 2 
at the process, activity and task level in Table C.5 of the standard.   
Utilizing this information all the relevant IEC 62304:2006 processes, activities and tasks were 
identified and mapped against ISO/IEC 12207:2008.  To achieve this a document was produced 
based on Table C.5 in the IEC 62304:2006 standard, but it was extended to include full details of the  
ISO/IEC 12207:1995 AMD 1 and AMD 2 tasks upon which the IEC 62304:2006 activities and tasks 
were based.  In Table C.5 (within IEC 62304:2006) these tasks were only referenced.  Analyzing this 
information and comparing it against ISO/IEC 12207:2008 allowed a direct mapping to be made 
between the processes and activities.  The tasks were also analyzed in detail and any differences 
highlighted and evaluated.  
Due to the restructuring that took place in ISO/IEC 12207:2008 and the changes required to facilitate 
this, the names and locations  of a number of processes, activities and  tasks changed from the 
previous release of the standard.  While at the task level only cosmetic adjustments had been made 
i.e. the use of the term “implementer” instead of “developer” and the addition of brief notes to a 
limited number of tasks.  The only relevant task omitted from ISO/IEC 12207:2008 which had been in 
ISO/IEC 12207:1995 AMD 1 and AMD 2 and referenced by IEC 62304:2006 was 6.4.2.2 Process 
Verification. This task had been used as the basis for the Verify Integration Tests Procedures task in 
IEC 62304:2006. While this task is absent from ISO/IEC 12207:2008 this is a requirement of IEC 
62304:2006 and it was therefore retained in the Medi SPICE PRM.  
Having identified the relevant ISO/IEC 12207:2008 processes these were compared with the Medi 
SPICE PRM processes and the next release of ISO/IEC 15504-5. This resulted in the selection of 13 
processes for inclusion in the IEC 62304 Medi SPICE PRM.  This included an extra process Hazard 
Mitigation which is not an ISO/IEC 12207:2008 process as it is medical device software specific.  
The processes which were identified as suitable for inclusion in the IEC 62304 PRM are as follows: 
 
• Software Implementation  
• Software Operation  
• Software Maintenance 
• Software Requirements Analysis 
• Software Architectural Design 
• Software Detailed Design 
• Software Construction 
• Software Integration 
• Software Qualification Testing 
• Software Configuration Management 
• Software Problem Resolution 
• Hazard Mitigation 
• Software Change Request Management 
 The relationship between these processes and IEC 62304:2006 are detailed in figure 1. 
The set of processes were then reviewed by both members of the IEC SC62A JWG3 Standards 
Working Group (the IEC 62304 development team) and the ISO/IEC 15504 community. Having 
agreed the processes, development of the IEC 62304 Medi SPICE PRM commenced. Each process 
was developed in line with the requirements of a PRM as defined in ISO/IEC 15504-2:2003 (ISO/IEC 
15504-2:2003, 2003).  This included assigning a process ID, a process name and defining a process 
purpose. 
 
Figure 1: The IEC 62304 Medi SPICE PRM processes for inclusion in the IEC 62304 PRM and their 
relationship to IEC 62304:2006. 
Based on the process purpose outcomes were identified.  The objective of each outcome was to 
contribute to the achievement of the process purpose. While the purpose and outcomes addressed 
the requirements of medical device software development and IEC 62304:2006 they were also 
inclusive of the requirements of the aligned, medical device standards and regulations. These 
included the FDA regulations and guidance documents, the requirements of the European MDD, ISO 
14971:2007, ISO 13485:2003 and IEC/TR 80002-1:2009.  The PRM recorded the source of each 
outcome and where relevant each outcome received an IEC 62304 safety classification. Once the IEC 
62304 Medi SPICE PRM was complete it was sent for review and evaluation by the ISO/IEC 15504 
community and the IEC SC62A JWG3 Standards Working Group. Based on the successful completion 
of these reviews and receipt of approval from the Standards Working Group it is now planned to 
include the IEC 62304 Medi SPICE PRM in the Appendix of the forthcoming release of IEC 62304. 
5. THE DEVELOPMENT OF LIGHTWEIGHT ASSESSMENT METHODS 
An important part of this ongoing research has been the development of 3 lightweight medical 
device software process centric assessment methods. The first was Med-Adept (Mc Caffery and 
Casey, 2010) which  is a lightweight assessment method that provides a means of assessing the 
software engineering capability of processes in relation to medical device software development.  
The goal of a Med-Adept assessment is to provide organizations who may be considering developing 
medical device software with an understanding of what they would need to have in place before 
embarking on such a strategy. To date a total of 8 Med-Adept assessments have taken place. 
Traceability plays a key role in the development of regulatory compliant medical device software 
(Mc Caffery and Casey, 2011). Med–Trace  was developed as  an assessment method specifically to 
assist companies to adhere to the traceability aspects of the medical device software standards 
(Casey and Mc Caffery, 2011). The objective of Med-Trace is to enable software development 
organizations to gain an appreciation of fundamental traceability best practices, based on the 
software engineering traceability literature, software engineering process models, and the medical 
device software guidelines and standards. To achieve this, Med-Trace may be used to diagnose an 
organization’s weaknesses and strengths with relation to their medical device software development 
traceability practices.  Med-Trace assessments have taken place in 4 companies and another 1 is 
currently in the planning stage.  
The third lightweight assessment method is Medi SPICE-Adept (Mc Caffery et al., 2011).  This 
method was initially based on the assessment of the 11 processes which made up the preliminary 
Medi SPICE PRM and PAM.  While these were the initial processes selected for Medi SPICE-Adept. 
These have been updated and will be expanded to provide coverage of all the Medi SPICE processes 
and subprocesses.  
Medi SPICE-Adept provides organizations with a lightweight assessment of each of the processes 
they select with the Medi SPICE Model.  This covers conformance to the specific requirements of the 
medical device regulations, standards, and guidance documents.  It also provides a method for 
carrying out an assessment, against the requirements for best software engineering practice for 
each process. That said, it is a lightweight method and the objective of undertaking a Medi SPICE-
Adept assessment, is not to receive formal certification or a capability rating. Rather it is to identify 
an organization’s strengths and weaknesses and to initiate and facilitate process improvement.  
5.1 Implementation of Medi SPICE- Adept  
The first Medi SPICE-Adept assessment took place in an Irish based medical device company 
Western Medical (a pseudonym). The company selected 10 processes and these were assessed over 
a two day period. Based on the results of the assessment, a findings report was prepared and 
presented. Process improvement objectives and a process improvement plan were collaboratively 
defined and developed with the company, based on the findings report. The improvement plan is 
currently being implemented and when this is complete the processes will be reassessed. A final 
detailed report will then be prepared and an updated improvement plan will also be provided. 
The findings report and improvement plan were very positively received by Western Medical as was 
the whole assessment procedure. A Medi SPICE-Adept assessment has also recently been 
successfully implemented in Australia by colleagues in Griffith University.  The Australian assessment 
provided similar positive feedback.  Given the level of demand the RSRG will continue to carry out 
additional Medi SPICE-Adept assessments both in Ireland and in collaboration with international 
colleagues. 
5.2 The Rationale for Developing Lightweight Assessment Methods 
There was a specific demand in the industry for the development of each of these lightweight 
assessment methods and their introduction has been welcomed. While this was the case, the 
purpose of their development was not solely to address these requirements.  The implementation of 
each of these methods has allowed key aspects of Medi SPICE to be tested and refined in an 
industrial setting. It has also provided relevant feedback which has been documented and 
incorporated into subsequent iterations of the Medi SPICE model. This is seen as a key element in 
the development of Medi SPICE.  This was also the rationale for the development of the lightweight 
assessment methods in tandem with the development of Medi SPICE. 
6. CONCLUSION  
It was decided in 2011 that Medi SPICE would conform to the structure of ISO/IEC 12207:2008 and 
the latest version of ISO/IEC 15504-5 (currently under ballot).  As outlined in section 3 the structure 
and processes which make up the current version of the Medi SPICE PRM were selected and agreed.  
Work on the detailed development of the PRM commenced.  
Following the invitation to add a subset of the Medi SPICE PRM to the next release of the IEC 62304 
standard, work commenced on the production of the IEC 62304 Medi SPICE PRM.  As outlined in 
Section 4 this work is now complete.  The development of the remaining Medi SPICE PRM and PAM 
processes is currently under way.  The full Medi SPICE PRM is scheduled for release in September 
2012.  This will be followed by the release of the Medi SPICE PAM by the end of December 2012.  
This will see the release of the full Medi SPICE process assessment and improvement model by 
January 2013. At that stage additional research will be undertaken on its implementation and to 
facilitate continued improvement. 
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